<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>MoveMint Research Labs – Research Data</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
<header class="site-header">
  <div class="brand">
    <img src="movemint-logo.png" alt="MoveMint Research Labs logo" class="brand-logo" />
    <div class="brand-text">
      <div class="brand-name">MoveMint <span>Research Labs</span></div>
      <div class="brand-tagline">For research use only. Not for human or veterinary use.</div>
    </div>
  </div>
  <nav class="nav-links">
    <a href="index.html">Items</a>
    <a href="checkout.html">Payment</a>
    <a href="research.html">Research Data</a>
    <a href="research-ar.html">Arabic Research</a>
  </nav>
</header>

<main>
  <section class="hero">
    <h1 class="gradient-text">Research Summaries & Item Information</h1>
    <p>
      The following summaries organize each peptide or compound by major research area.
      Descriptions are based on how these agents have been explored in scientific and
      pre-clinical studies and are intended for laboratory and educational context only.
    </p>
    <p class="hero-note">
      No claims of safety or efficacy are made. Nothing here is medical advice or dosing
      guidance for human use.
    </p>
  </section>

  <!-- METABOLIC & BODY-COMPOSITION RESEARCH -->
  <section>
    <h2>Metabolic & Body-Composition Research</h2>
    <div class="card-grid">

      <div class="card">
        <h3>5-Amino-1MQ</h3>
        <p>
          Small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme
          involved in methylation and energy metabolism, especially in adipose tissue.
          Research models suggest that decreasing NNMT activity can influence fat-cell
          size and fat-mass dynamics.
        </p>
        <p class="badge">Metabolic research</p>
      </div>

      <div class="card">
        <h3>AOD9604</h3>
        <p>
          Modified fragment of human growth hormone (hGH 176–191) with a disulfide bridge.
          Initially developed as a lipolytic research compound, it has been studied in
          animal models of fat metabolism, heart disease, osteoarthritis/cartilage
          repair, and broader metabolic-syndrome endpoints.
        </p>
        <p class="badge">Lipolysis / metabolic</p>
      </div>

      <div class="card">
        <h3>Tesofensine</h3>
        <p>
          Serotonin–noradrenaline–dopamine reuptake inhibitor (SNDRI) studied in
          neurodegenerative and metabolic contexts. Research has examined appetite
          suppression, body-weight changes and energy expenditure, as well as potential
          applications in Parkinson’s and Alzheimer’s disease models.
        </p>
        <p class="badge">Appetite / CNS metabolic</p>
      </div>

      <div class="card">
        <h3>Semaglutide</h3>
        <p>
          GLP-1 receptor analogue investigated for glycemic control, insulin secretion,
          and cardiovascular, hepatic and pulmonary endpoints. Studies also examine its
          effects on appetite, delayed gastric emptying and weight regulation in
          pre-clinical and clinical models.
        </p>
        <p class="badge">GLP-1 analogue</p>
      </div>

      <div class="card">
        <h3>Tirzepatide</h3>
        <p>
          Synthetic dual GIP/GLP-1 agonist developed for type 2 diabetes and obesity
          research. Experimental work explores its impact on blood-glucose reduction,
          insulin sensitivity, satiety signalling and body-fat distribution.
        </p>
        <p class="badge">GIP/GLP-1 dual agonist</p>
      </div>

      <div class="card">
        <h3>Retatrutide</h3>
        <p>
          Tri-agonist targeting GLP-1, GIP and glucagon receptors. Research focuses on
          how combined signalling at these receptors affects basal metabolism, fat and
          glycogen utilization, and longer-term weight trajectories in metabolic models.
        </p>
        <p class="badge">Triple incretin / glucagon</p>
      </div>

      <div class="card">
        <h3>MOTS-c</h3>
        <p>
          Mitochondria-derived peptide examined for effects on metabolic homeostasis,
          exercise capacity, adiposity and insulin resistance. Studies investigate roles
          in skeletal, bone and energy-balance pathways linked to longevity models.
        </p>
        <p class="badge">Mitochondrial metabolic peptide</p>
      </div>

      <div class="card">
        <h3>Melanotan-1</h3>
        <p>
          Melanocortin analogue used in research involving skin-pigmentation pathways,
          UV response, cardiovascular markers, inflammation, cognition, stroke recovery
          and body-weight regulation via melanocortin receptor signalling.
        </p>
        <p class="badge">Melanocortin / metabolic</p>
      </div>

      <div class="card">
        <h3>Melanotan-2</h3>
        <p>
          Alpha-MSH analogue investigated for its effects on melanocortin receptors
          involved in pigmentation, appetite, reward and sexual behaviour. Models assess
          changes in melanin production, feeding, addictive behaviour and arousal.
        </p>
        <p class="badge">Melanocortin / behaviour</p>
      </div>

    </div>
  </section>

  <!-- TISSUE REPAIR, WOUND HEALING & ANTI-FIBROTIC -->
  <section>
    <h2>Tissue Repair, Wound Healing & Anti-Fibrotic Research</h2>
    <div class="card-grid">

      <div class="card">
        <h3>BPC-157</h3>
        <p>
          Gastric-derived pentadecapeptide studied in models of muscle, tendon and
          ligament repair, as well as gastrointestinal integrity. Research has explored
          its effects in ulcer, “leaky gut” and inflammatory bowel models.
        </p>
        <p class="badge">Tissue repair</p>
      </div>

      <div class="card">
        <h3>Thymosin Beta-4</h3>
        <p>
          Peptide associated with actin modulation and tissue remodelling. Studies
          evaluate its role in new blood-vessel growth, wound healing, inflammation
          control and reduction of oxidative damage in cardiac and CNS models.
        </p>
        <p class="badge">Regeneration / remodeling</p>
      </div>

      <div class="card">
        <h3>B7-33</h3>
        <p>
          Peptide investigated for anti-fibrotic properties. Pre-clinical work suggests
          reductions in fibrosis in models of heart failure, lung injury and kidney
          damage, with interest in both acute and chronic fibrotic processes.
        </p>
        <p class="badge">Anti-fibrotic</p>
      </div>

      <div class="card">
        <h3>PEG-MGF</h3>
        <p>
          Pegylated mechano growth factor (MGF), a splice variant of IGF-1. Research
          explores its effects on lipid profiles, immune function and wound-healing
          dynamics, particularly in muscle or tissue stress models.
        </p>
        <p class="badge">Growth-factor variant</p>
      </div>

      <div class="card">
        <h3>KPV</h3>
        <p>
          Short peptide fragment studied for anti-inflammatory actions, including in
          inflammatory bowel and wound-healing models. Work has examined infection
          control, tissue repair and cosmetic outcome following injury.
        </p>
        <p class="badge">Anti-inflammatory / repair</p>
      </div>

      <div class="card">
        <h3>LL-37</h3>
        <p>
          Human cathelicidin-derived antimicrobial peptide. Research highlights
          antibacterial, antiviral and antifungal activity along with effects on
          inflammation, angiogenesis and potential anti-tumour activity.
        </p>
        <p class="badge">Host defense peptide</p>
      </div>

      <div class="card">
        <h3>ARA-290</h3>
        <p>
          Erythropoietin-derived peptide that signals through the innate repair
          receptor. Studies explore its impact on inflammatory regulation, neuropathic
          pain, wound repair, glycemic markers and lipid profiles.
        </p>
        <p class="badge">Innate repair signalling</p>
      </div>

      <div class="card">
        <h3>Thymalin</h3>
        <p>
          Thymulin-related peptide investigated for roles in inflammatory and pain
          pathways, immune modulation, cardiovascular protection, sleep regulation and
          longevity in various experimental models.
        </p>
        <p class="badge">Thymic / repair</p>
      </div>

      <div class="card">
        <h3>Oxytocin</h3>
        <p>
          Neuropeptide and hormone studied not only for social and behavioural circuits
          but also for wound-healing, cardiovascular markers and anxiety-related
          outcomes. Research models include social behaviour and autonomic regulation.
        </p>
        <p class="badge">Neuropeptide / repair</p>
      </div>

    </div>
  </section>

  <!-- GH AXIS, MUSCLE & ANABOLIC SIGNALING -->
  <section>
    <h2>GH Axis, Muscle & Anabolic Signaling</h2>
    <div class="card-grid">

      <div class="card">
        <h3>CJC-1295</h3>
        <p>
          Long-acting GHRH analogue evaluated for effects on pulsatile growth hormone
          and IGF-1. Used in research on muscle growth, tissue repair and metabolic
          control through GH-axis modulation.
        </p>
        <p class="badge">GHRH analogue</p>
      </div>

      <div class="card">
        <h3>Ipamorelin</h3>
        <p>
          Ghrelin-receptor agonist (GHS-R) classified as a selective GHRP. Research
          assesses its ability to increase GH and IGF-1 signalling with relatively
          focused receptor activity, in models of muscle, skeletal and connective-tissue
          support.
        </p>
        <p class="badge">GHRP / ghrelin agonist</p>
      </div>

      <div class="card">
        <h3>Tesamorelin</h3>
        <p>
          GHRH analogue studied in settings of abnormal fat distribution and metabolic
          dysfunction. Work includes GH/IGF-1 axis effects, visceral fat changes and
          potential cognitive endpoints.
        </p>
        <p class="badge">GHRH analogue</p>
      </div>

      <div class="card">
        <h3>Sermorelin</h3>
        <p>
          Short-acting GHRH analogue historically used to assess GH secretory capacity.
          Research has also explored influences on bone remodelling, scar structure and
          certain neurocognitive or seizure-related models.
        </p>
        <p class="badge">GHRH analogue</p>
      </div>

      <div class="card">
        <h3>GHRP-2</h3>
        <p>
          Growth hormone secretagogue that binds ghrelin/GHS receptors. Experimental
          data examine GH release, muscle growth, immune modulation and sleep-cycle
          architecture, including work on oral bioavailability.
        </p>
        <p class="badge">GH secretagogue</p>
      </div>

      <div class="card">
        <h3>Hexarelin</h3>
        <p>
          Synthetic GHRP analogue related to ghrelin. Beyond GH-axis research, it has
          been studied in cardiac-ischemia and heart-failure models, skeletal-muscle
          preservation and lipid-profile modulation.
        </p>
        <p class="badge">GHRP / cardiometabolic</p>
      </div>

      <div class="card">
        <h3>Follistatin-315</h3>
        <p>
          Naturally occurring activin and myostatin-binding protein. Research investigates
          its role in skeletal-muscle hypertrophy/hyperplasia, inflammatory signalling
          and reproductive-axis biology.
        </p>
        <p class="badge">Myostatin / activin binding</p>
      </div>

    </div>
  </section>

  <!-- NEUROCOGNITIVE & MOOD RESEARCH -->
  <section>
    <h2>Neurocognitive, Mood & CNS Research</h2>
    <div class="card-grid">

      <div class="card">
        <h3>Cerebrolysin</h3>
        <p>
          Peptide-based neurotrophic preparation studied in models of cognitive
          impairment, mood, neurodevelopmental conditions and neurotrauma. Research
          explores nerve repair, neurotoxicity mitigation and functional recovery.
        </p>
        <p class="badge">Neurotrophic preparation</p>
      </div>

      <div class="card">
        <h3>FGL</h3>
        <p>
          Peptide fragment derived from neural cell adhesion molecules. Experimental
          work examines neuroprotection, synaptic plasticity, memory, learning, mood
          regulation and neuroinflammation in models of brain injury and degeneration.
        </p>
        <p class="badge">Neuroprotective peptide</p>
      </div>

      <div class="card">
        <h3>Selank</h3>
        <p>
          Tuftsin-based peptide analogue investigated for anxiolytic, cognitive and
          pain-modulating effects. Studies look at memory, learning and stress-response
          pathways in CNS models.
        </p>
        <p class="badge">Anxiety / cognition</p>
      </div>

      <div class="card">
        <h3>Semax</h3>
        <p>
          ACTH-derived heptapeptide analogue with reported nootropic and
          neuroprotective properties in research. Work includes effects on BDNF,
          neurogenesis, immune markers and cardiovascular parameters.
        </p>
        <p class="badge">ACTH-derived neuropeptide</p>
      </div>

      <div class="card">
        <h3>Dihexa</h3>
        <p>
          Nootropic peptide derivative investigated for enhancement of cognitive
          function and synaptogenesis. It is studied in BDNF-related pathways and
          neurodegenerative models, including Alzheimer-type pathology.
        </p>
        <p class="badge">BDNF-linked nootropic</p>
      </div>

      <div class="card">
        <h3>PE-22-28</h3>
        <p>
          Spadin-derived peptide targeting TREK-1 potassium channels. Research explores
          fast-acting antidepressant-like effects, stroke recovery and neurodegenerative
          disease models.
        </p>
        <p class="badge">TREK-1 modulator</p>
      </div>

      <div class="card">
        <h3>P21</h3>
        <p>
          Nootropic peptide examined for its ability to influence BDNF levels,
          neurogenesis and the accumulation of amyloid and tau pathology in
          Alzheimer-type models.
        </p>
        <p class="badge">Neurogenesis / Alzheimer models</p>
      </div>

      <div class="card">
        <h3>DSIP</h3>
        <p>
          Delta sleep–inducing peptide studied in regulation of sleep, endocrine
          function, oxidative stress and cardiac contractility. Models also explore
          mood and depression-related endpoints.
        </p>
        <p class="badge">Sleep / endocrine peptide</p>
      </div>

    </div>
  </section>

  <!-- MITOCHONDRIAL, LONGEVITY & CELLULAR PROTECTION -->
  <section>
    <h2>Mitochondrial, Longevity & Cellular Protection</h2>
    <div class="card-grid">

      <div class="card">
        <h3>NAD⁺</h3>
        <p>
          Central redox coenzyme (nicotinamide adenine dinucleotide) involved in
          energy metabolism and DNA repair. Research evaluates roles in muscle
          performance, neuronal resilience and age-related functional decline.
        </p>
        <p class="badge">Redox cofactor</p>
      </div>

      <div class="card">
        <h3>Epithalon</h3>
        <p>
          Synthetic derivative of epithalamin investigated as a telomerase activator.
          Studies examine telomere dynamics, circadian hormone rhythms
          (cortisol/melatonin) and broader longevity-related parameters.
        </p>
        <p class="badge">Telomere / aging research</p>
      </div>

      <div class="card">
        <h3>FOXO4-DRI</h3>
        <p>
          Peptide designed to interfere with FOXO4–p53 interactions. Research models
          explore senescent-cell clearance, organ function, insulin signalling and
          oxidative-stress responses in the context of aging biology.
        </p>
        <p class="badge">Senolytic-oriented research</p>
      </div>

      <div class="card">
        <h3>Humanin</h3>
        <p>
          Mitochondrial-encoded micro-peptide. Studies assess its ability to protect
          cells from apoptosis, support metabolic efficiency and influence
          age-related disease models through mitochondrial signalling.
        </p>
        <p class="badge">Mitochondrial micro-peptide</p>
      </div>

      <div class="card">
        <h3>SS31</h3>
        <p>
          Mitochondria-targeted peptide examined for effects on ATP production,
          mitochondrial membrane potential, inflammatory cytokines and resilience
          in neurodegenerative and metabolic disease models.
        </p>
        <p class="badge">Mitochondrial-targeted peptide</p>
      </div>

    </div>
  </section>

  <!-- IMMUNE MODULATION & INFLAMMATION -->
  <section>
    <h2>Immune Modulation & Inflammation</h2>
    <div class="card-grid">

      <div class="card">
        <h3>Thymosin Alpha-1</h3>
        <p>
          Thymic peptide investigated as an immune modulator. Research explores
          antibacterial, antiviral and antifungal responses, immune-cell activation,
          tumour-immunity models, wound healing and vaccine-response augmentation.
        </p>
        <p class="badge">Immune modulation</p>
      </div>

      <div class="card">
        <h3>Vilon</h3>
        <p>
          Peptide with immunomodulatory and anti-aging interest. Studies examine its
          effects on immune regulation, tissue repair and tumour-related models.
        </p>
        <p class="badge">Immunomodulatory peptide</p>
      </div>

      <div class="card">
        <h3>VIP (Vasoactive Intestinal Peptide)</h3>
        <p>
          Neuropeptide examined for anti-inflammatory, anti-fibrotic and neuroprotective
          actions. Research includes immune-regulation, CNS protection and fibrotic
          disease models.
        </p>
        <p class="badge">Neuropeptide / immune</p>
      </div>

    </div>
  </section>

  <!-- REPRODUCTIVE, SEXUAL & HORMONAL AXIS -->
  <section>
    <h2>Reproductive, Sexual & Hormonal Axis</h2>
    <div class="card-grid">

      <div class="card">
        <h3>Kisspeptin-10</h3>
        <p>
          Peptide that stimulates GnRH and LH release. Research focuses on reproductive
          hormone regulation, testosterone dynamics and potential reversal of certain
          age-related changes in hypothalamic–pituitary–gonadal signalling.
        </p>
        <p class="badge">Reproductive-axis peptide</p>
      </div>

      <div class="card">
        <h3>PT-141</h3>
        <p>
          Melanocortin-receptor agonist studied in models of sexual arousal and
          haemodynamic regulation. Experimental work also explores immune activation
          and haemorrhage-related applications.
        </p>
        <p class="badge">Melanocortin / sexual function</p>
      </div>

    </div>
  </section>

  <!-- ONCOLOGIC & CELL-TARGETING RESEARCH -->
  <section>
    <h2>Oncologic & Cell-Targeting Research</h2>
    <div class="card-grid">

      <div class="card">
        <h3>PNC-27</h3>
        <p>
          Peptide designed to bind HDM-2 and modulate p53 activity. Research examines
          selective effects on cancer-cell membranes and tumour-cell viability in
          pre-clinical oncologic models.
        </p>
        <p class="badge">Oncology-focused peptide</p>
      </div>

    </div>
  </section>

  <section class="disclaimer">
    <strong>Global disclaimer:</strong> All compounds listed are supplied strictly as
    research materials for qualified laboratories. They are not drugs, foods,
    supplements or cosmetics and must not be used for human or veterinary
    administration. End users are responsible for appropriate safety measures and
    regulatory compliance.
  </section>
</main>

<footer>
  &copy; <span id="year"></span> MoveMint Research Labs. For research use only.
</footer>

<script>
  document.getElementById("year").textContent = new Date().getFullYear();
</script>
</body>
</html>
